Effects of Research Policy in Biotechnology: An Empirical Agent-Based Model of Knowledge Generation

Over the recent past, we can observe increasing interest in the ex-ante impact assessment of research policy, mainly related to the growing importance of accountability and limited budgets. However, existing methods often lack quantitative scenarios that go beyond extrapolations of current trends. This study addresses this research gap by proposing an empirical agent-based model (ABM) of knowledge generation in a system of researching firms. With our emphasis on the empirical calibration of ABMs, we intend to conduct scenario simulations applicable to real world contexts – in this study illustrated by means of an ABM on the Austrian biotechnology sector. In our model, effects of public research policy on the knowledge-related system output – measured by the patent portfolio – are under scrutiny. By this, the study contributes to the literature on ABMs in several aspects: Building on an existing concept of knowledge representation, we advance the model of individual and collective knowledge generation in firms by conceptualising policy intervention and corresponding output indicators. Furthermore, we go beyond symbolic ABMs of knowledge production by using empirical patent data as knowledge representations, adopt an elaborate empirical initialisation and calibration strategy using company data, and utilise econometric techniques to generate a sector-specific fitness function that determines the model output. With this model, we are able to conduct scenario analyses on effects of different public research funding schemes in the field of biotechnology. The results demonstrate that an empirically calibrated and transparent model design increases credibility and robustness of the ABM approach in the context of ex-ante impact assessment of public research policy.

[1]  Michaela Trippl,et al.  Knowledge links in high-technology industries: markets, networks or milieu? The case of the Vienna biotechnology cluster , 2007 .

[2]  Bronwyn H Hall,et al.  Heart of Darkness: Modeling Public-Private Funding Interactions Inside the R&D Black Box , 2000 .

[3]  Bruno Van Pottelsberghe,et al.  The impact of public R&D expenditure on business R&D* , 2003 .

[4]  Manfred M. Fischer,et al.  Joint Knowledge Production in European R&D Networks: Results from a Discrete Choice Modeling Perspective , 2013 .

[5]  J. Hoekman,et al.  The geography of collaborative knowledge production in Europe , 2009 .

[6]  Z. Griliches,et al.  Do Subsidies to Commercial R&D Reduce Market Failures? Microeconomic Evaluation Studies , 1999 .

[7]  Pravin K. Trivedi,et al.  Regression Analysis of Count Data , 1998 .

[8]  Walter W. Powell,et al.  Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community , 2004, Organ. Sci..

[9]  Herbert Dawid,et al.  Agent-based Models of Innovation and Technological Change , 2006 .

[10]  Walter W. Powell,et al.  Biotechnology: Its origins, organization, and outputs , 2007 .

[11]  Olivier Barreteau,et al.  Designing Empirical Agent-Based Models: An Issue of Matching Data, Technical Requirements and Stakeholders Expectations , 2014 .

[12]  Andreas Pyka,et al.  Innovation Networks - A Simulation Approach , 2001, J. Artif. Soc. Soc. Simul..

[13]  Boris Lokshin,et al.  What Does it Take for an R&D Tax Incentive Policy to be Effective? , 2009 .

[14]  Ugur Muldur,et al.  Ex-ante impact assessment of research programmes: The experience of the European Union's 7th Framework Programme , 2007 .

[15]  Arie Rip,et al.  Co-word maps of biotechnology: An example of cognitive scientometrics , 1984, Scientometrics.

[16]  David L. Deeds,et al.  An Analysis of the Critical Role of Public Science in Innovation: The Case of Biotechnology , 2000 .